About C-X-C chemokine receptor type 4
C-X-C chemokine receptor type 4 (CXCR4) is a protein
from Homo sapiens identified by UniProt accession
P61073, 352 residues long.
MolForge cross-references it against 0 known binders and
1,311 disease associations.
Target properties
| Protein name | C-X-C chemokine receptor type 4 |
| UniProt accession | P61073 |
| Gene | CXCR4 |
| Organism | Homo sapiens |
| Length | 352 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (1311)
Diseases linked to this target (Open Targets).
- WHIM syndrome · score 0.79
- monocyte count · score 0.66
- multiple myeloma · score 0.63
- neutrophil count · score 0.58
- leukocyte count · score 0.57
- HIV infection · score 0.56
- non-Hodgkins lymphoma · score 0.53
- lymphoma · score 0.52
- severe congenital neutropenia · score 0.46
- monocyte percentage of leukocytes · score 0.43
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P61073-F1 | alphafold | PREDICTED | 82.26 | — |
Amino-acid sequence (352 residues)
MEGISIYTSD NYTEEMGSGD YDSMKEPCFR EENANFNKIF LPTIYSIIFL TGIVGNGLVI LVMGYQKKLR SMTDKYRLHL SVADLLFVIT LPFWAVDAVA NWYFGNFLCK AVHVIYTVNL YSSVLILAFI SLDRYLAIVH ATNSQRPRKL LAEKVVYVGV WIPALLLTIP DFIFANVSEA DDRYICDRFY PNDLWVVVFQ FQHIMVGLIL PGIVILSCYC IIISKLSHSK GHQKRKALKT TVILILAFFA CWLPYYIGIS IDSFILLEII KQGCEFENTV HKWISITEAL AFFHCCLNPI LYAFLGAKFK TSAQHALTSV SRGSSLKILS KGKRGGHSSV STESESSSFH SS
Explore C-X-C chemokine receptor type 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets